Navigation Links
Sangart Enhances Leadership Team Bringing Superior Depth of Expertise
Date:2/15/2012

SAN DIEGO, Feb. 15, 2012 /PRNewswire/ -- Sangart, Inc., a privately held biopharmaceutical company focused on the research, development and commercialization of oxygen-therapeutic agents, today announced three new appointments to its executive team. These additions continue Sangart's tradition of retaining some of the industry's most influential leaders, while adding to the depth of expertise that the company provides.

"Sangart believes the quality of our executives should echo the importance of our development programs, so we continue to invest in expanding our leadership team," said Brian O'Callaghan, President and Chief Executive Officer of Sangart. "The recent addition of several key executives, coupled with the talent of our existing team, positions Sangart to bring important lifesaving treatments to market, including MP4OX, an investigational therapy for trauma patients, and MP4CO, which is currently in Phase 1b study for the treatment of sickle cell disease."

Sangart's recent leadership team additions include:

  • Frank Booth, MA MSc BM BCh FACS, Chief Medical Officer – Dr. Booth was recently promoted to the role of Chief Medical Officer. Dr. Booth has more than 20 years of experience as a trauma and critical care surgeon and as a clinical investigator. Prior to joining Sangart, he worked in clinical development roles at Novo Nordisk and at Eli Lilly & Company.
  • Mary Rose Keller, Vice President of Clinical Operations – Ms. Keller will be responsible for the execution of all clinical programs, including sickle cell, trauma and future treatments at Sangart. She brings to the company more than 25 years of experience in clinical research and clinical trial execution and has been involved with numerous, successful regulatory submissions for companies such as Agouron, Pfizer and Shire Pharmaceuticals.
  • Carmen Betancourt-Riche, MBA, Vice President of Regulatory Affairs and Quality Assurance – Ms. Betan
    '/>"/>

  • SOURCE Sangart, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. Sangart, Inc. Initiates Dosing in Phase II Study of Hemospan(R) in Chronic Critical Limb Ischemia
    2. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
    3. Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
    4. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
    5. Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease
    6. Sangart Announces Closing of $50 Million Series G Financing
    7. Sangart Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
    8. Sangart Initiates Phase 1b Study of MP4CO in Patients With Sickle Cell Disease
    9. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
    10. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
    11. Des Moines Register Reports SpectraScience LUMA Enhances Cervical Cancer Exams
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/28/2014)... Nov. 28, 2014  (Booth #7309, North Hall) — ... its newest product, DCMSYS Interface WebBridge, at the 100th ... at McCormick Place, Chicago, Illinois . ... Designed for medical facilities of any size, ... to upload any non-standard data (e.g. JPEG, TFF, PDF, ...
    (Date:11/28/2014)... 2014 Chinese magnesium alloy maker DongGuan Eontec ... magnesium alloy bone fixation screw has received Chinese regulatory ... and instrument and that the company acknowledges receipt of ... Science and Technology Daily journalists Wang Xiangming ... and founder, Professor Li Yangde , has been ...
    (Date:11/27/2014)... -- Javon Bea Mercy Health System President and ... Janesville Craig High School and Janesville Parker High School ... and Janesville Police and ... Janesville School District. The event was ... schools and other organizations with the resources needed to ...
    Breaking Medicine Technology:Dicom Systems Announces WebBridge Interface at RSNA 2014 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 3Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 4Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 2Mercy Health System, Janesville Police / Fire, provide casualty training to high school faculty 3
    ... Medica,s ONCOLOGY and CancerNetwork today announced ... the clinical genetics service at Memorial Sloan-Kettering ... genetic testing in gastrointestinal cancers . ... colleagues bring clarity to when, why—and to what end—to refer ...
    ... Panasonic Healthcare Group today announced a new ... supplier for the hearing professional, which will allow ... at www.panasonic-hearingshop.com .  This is the first ... available for hearing care professionals to order online.    ...
    Cached Medicine Technology:UBM Medica's ONCOLOGY to Feature Special Content on Role of Genetic Testing in GI Cancers 2Panasonic Reaches Distribution Agreement With The Hearing Shop 2Panasonic Reaches Distribution Agreement With The Hearing Shop 3Panasonic Reaches Distribution Agreement With The Hearing Shop 4
    (Date:11/28/2014)... 2014 BambooFlooringChina.com has been recognized as ... Recently, the business has announced its new strand ... big discount on these new models. , Based on ... hands, without carpenter machines involved. It is crafted on ... great for do-it-yourselfers without hard work on installation, also ...
    (Date:11/28/2014)... November 28, 2014 Dr. Diane Walder, ... , announced the addition of Dr. Bridgit Nolan to ... the practice after having completed her dermatology residency at ... Dr. Walder invited Dr. Nolan to join ... surgery and cosmetic dermatology. Not only does Dr. Nolan ...
    (Date:11/28/2014)... 2014 Dr. Andrew Campbell, one of ... the expansion of Quintessa Aesthetic Center into a third ... at W307 N1497 Golf Road in Suite 200 and ... Campbell, the new Delafield location will offer a variety ... including: Botox, filler injectables , micro laser peels, ...
    (Date:11/28/2014)... Melbourne, Australia (PRWEB) November 28, 2014 ... has undergone healthy growth over the past five ... population's increasing acceptance of therapies that are either ... conventional treatments. According to IBISWorld industry analyst David ... the ageing population and growing private health insurance ...
    (Date:11/28/2014)... Nov. 27, 2014 (HealthDay News) -- Planning on seconds ... chronic heartburn -- clinically known as gastroesophageal reflux disease (GERD) ... Dr. Jordan Josephson, an ear, nose and throat specialist at ... tips to help manage GERD on Thanksgiving: ... at least two small meals throughout the day. It,s also ...
    Breaking Medicine News(10 mins):Health News:BambooFlooringChina.com Introduces Its New Strand Woven Bamboo Flooring Collection 2Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:Don't Let Chronic Heartburn Spoil Your Thanksgiving Feast 2
    ... , , PITTSBURGH, Sept. 14 ... is prototyping an innovative stroke treatment device designed to speed up ... , Michele Migliuolo, NeuroInterventions President and ... presentation at the 3 Rivers Venture Fair in Pittsburgh on Sept. ...
    ... NY, Sept. 13 /PRNewswire-FirstCall/ - (OTCBB: GVBP.OB) - GENova ... and develops novel drug targets that disrupt the advance ... Dr. Philip Gould as a Member Designate of its ... his career experience in multinational blue chip drug discovery ...
    ... ROCHESTER, Minn. -- Mayo Clinic researchers say that "teachable ... them diagnose cardiac infections without an invasive exam. Those ... on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco. ... sometimes chambers of the heart -- can be a ...
    ... say they,ll donate than do, leaving long waits for transplants ... and large say they support the idea of donating some ... lives, reality presents a different picture. , Just 38 percent ... organ and tissue donors, according to a report this year ...
    ... , , DENVER, Sept. 11 ... kidney care services for those diagnosed with chronic kidney disease (CKD), kicks ... events raising funds and awareness of CKD across the nation -- on ... (Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO ) , , The ...
    ... ... PhD, JD, is Keynote Speaker on the Failed War on Drugs , ... Las Vegas, NV (PRWEB) September 11, 2009 -- ... Drug Policy Alliance advocating for drug reform in the United States as keynote speaker former ...
    Cached Medicine News:Health News:Rapid-response Technology from NeuroInterventions, Inc. Aims to Quickly Restore Brain's Blood Flow After a Stroke 2Health News:GENova appoints Dr. Philip Gould to Scientific Advisory Board 2Health News:GENova appoints Dr. Philip Gould to Scientific Advisory Board 3Health News:Artificial intelligence helps diagnose cardiac infections 2Health News:For Organ Donation, Intent and Reality Don't Align 2Health News:For Organ Donation, Intent and Reality Don't Align 3Health News:DaVita Launches Nationwide Series of Kidney Awareness Run/Walks 2Health News:Healthcare Legal Issues Take the Stage at PAINWeek 2009 2Health News:Healthcare Legal Issues Take the Stage at PAINWeek 2009 3
    Markham-Meyerding Hemilaminectomy Retractors, self-retaining, Right....
    Bookwalter Spinal Retractor...
    The TEW Cranial/Spinal Retractor is designed for posterior fossa or intraspinal microsurgery where retraction is required....
    ... Infuse Bone Graft represents an rhBMP-2 (recombinant ... with a bovine-derived absorbable collagen sponge (ACS) ... fusion device is indicated for spinal fusion ... disc disease (DDD) at one level from ...
    Medicine Products: